디지털 환자 모니터링 기기 시장 보고서 : 모니터링 방식, 제품 유형, 최종사용자, 지역별(2026-2034년)

The global digital patient monitoring devices market size reached USD 184.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 912.0 Billion by 2034, exhibiting a growth rate (CAGR) of 18.85% during 2026-2034. The rising prevalence of chronic diseases, shift towards remote patient monitoring, and technological advancements are primarily driving the digital patient monitoring market growth.

DIGITAL PATIENT MONITORING DEVICES MARKET ANALYSIS:

• Major Market Drivers: Significant growth in the healthcare industry, the rising demand for continuous monitoring devices, and the increasing prevalence of chronic medical ailments, such as hypertension, asthma, blood pressure, and diabetes, represent key factors majorly driving the digital patient monitoring devices market growth.
• Key Market Trends: Various advancements in technology, such as the introduction of smart digital patient monitoring devices that assist in the quick analysis of common physiological parameters, are providing an impetus to the market growth. Additionally, the increasing demand for various sensor-based wearable monitoring devices, such as continuous glucose monitors that help in tracking the patient's blood sugar levels on a real-time basis, is favoring the digital patient monitoring devices market demand.
• Competitive Landscape: Some of the prominent digital patient monitoring devices companies include Abbott, Baxter International Inc., GE HealthCare, Masimo Corporation, Medtronic plc, Nihon Kohden Corporation, OMRON Healthcare Co., Ltd., and VitalConnect, among many others.
• Geographical Trends: According to the digital patient monitoring devices market dynamics, North America is dominating the overall market owing to the increasing prevalence of chronic diseases, rising healthcare costs, and advancements in technology such as IoT and AI.
• Challenges and Opportunities: Regulatory hurdles, integration with healthcare systems, and data privacy security concerns are some of the key challenges that the market is facing. However, the increasing prevalence of chronic diseases, such as diabetes, cardiovascular ailments, respiratory disorders, etc., creates a growing demand for continuous patient monitoring solutions.

DIGITAL PATIENT MONITORING DEVICES MARKET TRENDS:

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic ailments has created a demand for continuous monitoring solutions. For instance, according to an article published by the Mayo Clinic, in 2020, an estimated 523 million people globally reported some type of CVD, with nearly 19 million fatalities attributed to it. This accounts for around 32% of all global deaths, an 18.7% rise from 2010. Digital patient monitoring devices enable healthcare providers to remotely monitor patients' health parameters and intervene early, leading to better management of chronic conditions and reduced healthcare costs. These factors are further contributing to the digital patient monitoring devices market share.

Increasing Geriatric Population

The increasing geriatric population is one of the key factors driving the digital patient monitoring devices market. For instance, according to an article published by the World Health Organization, by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up will rise from 1 billion in 2020 to 1.4 billion. By 2050, the global population of persons aged 60 and up will double (2.1 billion). The number of people aged 80 and older is anticipated to triple between 2020 and 2050, reaching 426 million. Many elderly individuals prefer to age in place, staying in their own homes rather than moving to assisted living facilities or nursing homes. Digital monitoring devices support aging in place by providing healthcare providers and caregivers with real-time data on the patient's health status remotely. These factors are further bolstering the digital patient monitoring market revenue.

Technological Advancements

Technological advancements are significantly driving the growth of the digital patient monitoring devices market. Wearable devices, such as smartwatches, fitness trackers, and patches, allow for seamless integration into daily life, enabling patients to monitor their health in real-time and healthcare providers to gather data remotely. For instance, in July 2024, KORE, a Georgia-based IoT startup, and mCare Digital launched mCareWatch 241, a wristwatch designed for virtual patient monitoring. The watch has a geo-fence alert, a pedometer, a heart rate monitor, speed dialing, fall detection, a call feature that allows users to request emergency assistance, a web dashboard and mobile app, and GPS tracking and reminders. These factors are positively influencing the digital patient monitoring devices market forecast.

GLOBAL DIGITAL PATIENT MONITORING DEVICES INDUSTRY SEGMENTATION:

Breakup by Monitoring Type:

• Wireless Sensor Technology
• mHealth
• Telehealth
• Wearable Devices
• Remote Patient Monitoring

Currently, wearable devices hold the majority of the total market share

According to the digital patient monitoring devices market outlook, wearable devices such as smartwatches and fitness trackers have gained widespread popularity among consumers for tracking fitness metrics, sleep patterns, and overall wellness. Consumers are increasingly using these devices to monitor health indicators like heart rate variability, stress levels, and even blood oxygen saturation. For instance, in June 2023, STAT Health, a digital health company based in the U.S., launched a wearable general wellness device that can be worn 24/7 that analyzes blood flow to the brain to help with recognizing issues in the body that arise when standing.

Breakup by Product:

• Diagnostic Monitoring Devices
  • Vital Sign Monitors
  • Sleep Monitors
  • Fetal Monitors
  • Neuromonitors
  • Others
• Therapeutic Monitoring Devices
  • Insulin Monitors
  • Respiratory Monitors
  • Others

Diagnostic monitoring devices currently exhibit a clear dominance in the market

As per the digital patient monitoring devices market outlook, diagnostic monitoring devices are indispensable for accurate diagnosis, disease monitoring, and treatment planning across various medical specialties. Healthcare providers rely on these devices to detect and monitor diseases early, optimize treatment strategies, and improve patient outcomes. Moreover, continuous improvements in sensor technology, connectivity (IoT), artificial intelligence (AI), and data analytics enhance the capabilities and accuracy of diagnostic monitoring devices. For instance, in September 2023, Beacon Biosignals announced the FDA 510(k) Clearance for the Dreem 3S, an advanced wearable headband with integrated machine learning algorithms to capture electroencephalogram (EEG) data from the brain to monitor sleep architecture and help in the diagnosis of disturbed sleep.

Breakup by End User:

• Hospitals
• Home Settings
• Ambulatory Surgical Centers (ASC)

Hospitals account for the largest market share

Digital patient monitoring devices enable hospitals to continuously monitor patients' vital signs, physiological parameters, and health metrics in real time. These devices provide accurate and timely data, facilitating early detection of clinical deterioration, prompt interventions, and improved patient safety.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America currently dominates the global market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America dominates the global market.

According to the digital patient monitoring devices market statistics, North America faces a rising prevalence of chronic diseases, such as diabetes, cardiovascular ailments, and respiratory disorders. For instance, as per the November 2022 study released by the Canadian Chronic Disease Surveillance System, around 6.3 million adults 65 years of age and above are anticipated to be living with chronic diseases in the near future. Digital patient monitoring devices enable continuous monitoring of vital signs, glucose levels, blood pressure, and other health metrics, empowering patients and healthcare providers to manage chronic conditions more effectively.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global digital patient monitoring devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered are:

• Abbott
• Baxter International Inc.
• GE HealthCare
• Masimo Corporation
• Medtronic plc
• Nihon Kohden Corporation
• OMRON Healthcare Co., Ltd.
• VitalConnect

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Digital Patient Monitoring Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Monitoring Type

• 6.1 Wireless Sensor Technology
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 mHealth
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Telehealth
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Wearable Devices
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Remote Patient Monitoring
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Product

• 7.1 Diagnostic Monitoring Devices
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Vital Sign Monitors
    • 7.1.2.2 Sleep Monitors
    • 7.1.2.3 Fetal Monitors
    • 7.1.2.4 Neuromonitors
    • 7.1.2.5 Others
  • 7.1.3 Market Forecast
• 7.2 Therapeutic Monitoring Devices
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Insulin Monitors
    • 7.2.2.2 Respiratory Monitors
    • 7.2.2.3 Others
  • 7.2.3 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Home Settings
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Ambulatory Surgical Centers (ASC)
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Baxter International Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 SWOT Analysis
  • 14.3.3 GE HealthCare
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Masimo Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Medtronic plc
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Nihon Kohden Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 OMRON Healthcare Co., Ltd.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 VitalConnect
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis